Zydus Cadila launches remdesivir at Rs 2800 per 100 mg vial EP News Bureau Aug 13, 2020 To be sold under brand name Remdac, the API for the drug has been developed and manufactured at the company’s API manufacturing…
HCQ in COVID-19: Repurposing with a purpose in the background of a ‘lost cause’ EP News Bureau Jul 18, 2020 Dr Dhananjay Bakhle shares a rebuttal to an article, Explained: What works (and does not) in Covid treatment', written by Dr…
Pharma exports record 10 per cent growth in dollar terms during Q1 FY’21 Usha Sharma Jul 17, 2020 Pharmexcil requests the government to resume Air India flights to Africa as it is the second-largest importer of Indian pharma…
Why drug repurposing needs first good science, then hope Viveka Roychowdhury Jun 24, 2020 The COVID-19 adversity has proved to be an opportunity to galvanise drug repurposing and development in India. But it is important…
US FDA warns against co-administration of remdesivir and chloroquine or HCQ EP News Bureau Jun 16, 2020 The drug regulator informs that this may reduce the antiviral activity of remdesivir and lessen the effectiveness of COVID-19…
Government lifts export restrictions on HCQ APIs, formulations Usha Sharma Jun 11, 2020 DGFT to issue a formal notification
Favipiravir exports during COVID-19 outbreak reaffirm India’s position as Pharmacy to the World:… EP News Bureau May 1, 2020 Favipiravir is the fourth most evaluated repurposed drug after HCQ, lopinavir/ritonavir combination, and recombinant interferon…